CRP and metabolic disease: MLP + P and MLP + BioPB showed differing effects on blood lipids and inflammatory markers: reductions in cholesterol and LDL-cholesterol were greater and more persistent in the MLP + BioPB group, whereas the CRP levels (high CRP levels are linked to inflammation and metabolic disorders) were significantly reduced in the MLP + P group only.